Bipolar Depression vs. Unipolar Depression: Clinical Distinctions That Matter

The depressive phase of bipolar disorder is often indistinguishable from unipolar depression based on symptoms alone. Both involve low mood, loss of interest, fatigue, sleep changes, cognitive slowing, and functional impairment. What distinguishes them — and what makes the distinction clinically consequential — is not the depression itself but the history of elevated mood states and the treatment implications that follow.

Features That May Suggest Bipolar Depression

Several clinical features, while not definitive, suggest bipolar depression rather than unipolar. Hypersomnia — sleeping significantly more than usual — is more common in bipolar depression than in unipolar depression, where insomnia is more typical. Leaden fatigue — a physical heaviness that accompanies the depression and affects movement and motivation — is more characteristic of bipolar depression. Psychomotor retardation — visible slowing of movement, speech, and thought — is more prominent.

Bipolar depression is also more likely to present with atypical depressive features — including hypersomnia, increased appetite, leaden paralysis, and mood lability — which are more common in bipolar depression than in unipolar depression. Psychomotor retardation, psychotic features, and an abrupt onset and offset of the depressive episode are also more suggestive of bipolar depression. However, no single symptom reliably distinguishes bipolar from unipolar depression on its own — the diagnosis ultimately rests on identifying a history of hypomanic or manic episodes. The NIMH notes that bipolar depression is treated differently from unipolar depression: often with a mood stabilizer or an atypical antipsychotic, and antidepressants are not used alone.

The Critical Treatment Difference

The most clinically significant difference between bipolar depression and unipolar depression is the role of antidepressants. In unipolar depression, antidepressants are a first-line treatment with a well-established evidence base. In bipolar depression, antidepressants are used cautiously, typically only in combination with a mood stabilizer, and sometimes not at all — because antidepressants used without mood stabilization in bipolar disorder can trigger hypomanic or manic episodes, can increase the frequency of mood cycling, and in some presentations can destabilize the condition over time.

This does not mean antidepressants are never used in bipolar depression. They are, in some presentations and in combination with mood stabilizers. But the clinical decision requires careful assessment of the full bipolar presentation and the individual’s history, and the treatment approach is meaningfully different from unipolar depression management. Using a treatment that works well for one condition in the other can produce harm — which is why accurate differential diagnosis between bipolar depression and unipolar depression is clinically essential.

Lamotrigine and Other Evidence-Based Options

Lamotrigine is FDA-approved to help delay mood episodes, including depression, in bipolar I disorder, and guidelines list it among first-line options for bipolar I depression. Quetiapine has evidence for bipolar depression across bipolar types. Lithium, while primarily studied for mania prevention, has some evidence for depressive phase stabilization as well.

Systematic inquiry about the full longitudinal mood pattern — across years and decades — is what allows accurate identification of a bipolar spectrum condition versus unipolar depression. Bipolar disorder assessment is not simply about the current episode but about the pattern of episodes over time.

Frequently Asked Questions

Can you tell from symptoms alone whether depression is bipolar or unipolar?

Not definitively. The depressive symptoms themselves overlap substantially. What establishes the diagnosis is the presence or absence of a history of hypomanic or manic episodes — which is why taking a complete longitudinal mood history is essential. Some clinical features (hypersomnia, leaden fatigue, psychomotor retardation) increase the clinical suspicion for bipolar depression, but they are not sufficient alone.

Is it dangerous to take antidepressants if you have undiagnosed bipolar disorder?

There is meaningful risk. Antidepressants used without mood stabilizer coverage in someone with undiagnosed bipolar disorder can trigger hypomanic or manic episodes, can increase cycling frequency, and can in some presentations destabilize the course of the illness. This does not mean antidepressants are always harmful in bipolar disorder — but the risk profile is different than in unipolar depression, and accurate diagnosis before initiating treatment matters.

Which medications are used for bipolar depression?

Lamotrigine is FDA-approved to help delay mood episodes, including depression, in bipolar I disorder, and is among the first-line options for bipolar I depression. Quetiapine is FDA-approved for depressive episodes of bipolar disorder; the studies behind that approval included people with bipolar I and bipolar II. Lithium is primarily studied for mania prevention but has some depressive phase benefits. The choice depends on the specific presentation, history of prior treatment responses, and individual clinical factors.

If I’m already on an antidepressant and might have bipolar disorder, should I stop it?

No. Please don’t stop a medication on your own; some can cause withdrawal symptoms or a return of symptoms if stopped suddenly. If you have concerns about whether your diagnosis or treatment is accurate, the appropriate step is a thorough clinical evaluation to assess the full picture, and any medication changes should be made with your provider.

If depression has been your primary diagnosis but treatment has not fully worked — or if you have noticed periods of elevated energy, reduced sleep need, or increased activity alongside the depression — a thorough evaluation for the full mood pattern is worth pursuing.